{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:29:10Z","timestamp":1782361750872,"version":"3.54.5"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T00:00:00Z","timestamp":1384473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0079864","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T22:58:05Z","timestamp":1384556285000},"page":"e79864","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Polymorphisms in XPD Gene Could Predict Clinical Outcome of Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer Patients: A Meta-Analysis of 24 Studies"],"prefix":"10.1371","volume":"8","author":[{"given":"Qin","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics, 2002","volume":"52","author":"A Jemal","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P","article-title":"Estimates of the worldwide incidence of 25 major cancers in 1990","volume":"80","author":"DM Parkin","year":"1999","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2008.17.2056","article-title":"First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?","volume":"26","author":"LH Einhorn","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnci\/djk196","article-title":"Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis","volume":"99","author":"A Ardizzoni","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/JTO.0b013e3182272273","article-title":"Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival","volume":"6","author":"L Liu","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Liu L, Wu J, Zhong R, Wu C, Zou L, <etal>et al<\/etal>.. (2012) Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. Mol Carcinog.","DOI":"10.1002\/mc.21942"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1002\/cncr.26154","article-title":"A functional polymorphism (-1607 1G\u2014&gt;2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer","volume":"117","author":"L Liu","year":"2011","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e62485","DOI":"10.1371\/journal.pone.0062485","article-title":"Replication study in Chinese population and meta-analysis supports association of the 5p15.33 locus with lung cancer","volume":"8","author":"J Ke","year":"2013","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<160::AID-IJC10>3.0.CO;2-J","article-title":"DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy","volume":"89","author":"PJ van de Vaart","year":"2000","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.embor.7400418","article-title":"Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells","volume":"6","author":"Q Wu","year":"2005","journal-title":"EMBO Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1349-7006.2007.00557.x","article-title":"Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"98","author":"K Azuma","year":"2007","journal-title":"Cancer Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"S Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref13","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer","volume":"8","author":"RV Lord","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref14","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"MR Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/carcin\/21.5.965","article-title":"Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells","volume":"21","author":"EJ Duell","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","article-title":"XPD polymorphisms: effects on DNA repair proficiency","volume":"21","author":"RM Lunn","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","article-title":"Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer","volume":"15","author":"D Isla","year":"2004","journal-title":"Ann Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/1078-0432.CCR-07-1364","article-title":"Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine\/cisplatin-treated advanced non-small cell lung cancer patients","volume":"14","author":"C Tibaldi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF03256406","article-title":"Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer","volume":"15","author":"J Mathiaux","year":"2011","journal-title":"Mol Diagn Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"JF Tierney","year":"2007","journal-title":"Trials"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"P Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"DG Altman","year":"2003","journal-title":"BMJ"},{"key":"ref23","first-page":"4899","article-title":"Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells","volume":"62","author":"T Furuta","year":"2002","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/annonc\/mdj135","article-title":"Polymorphisms in DNA repair genes modulate survival in cisplatin\/gemcitabine-treated non-small-cell lung cancer patients","volume":"17","author":"R de las Penas","year":"2006","journal-title":"Ann Oncol"},{"key":"ref25","first-page":"5457","article-title":"Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD","volume":"62","author":"R Aloyz","year":"2002","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.lungcan.2010.10.011","article-title":"No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis","volume":"72","author":"M Yin","year":"2011","journal-title":"Lung Cancer"},{"key":"ref27","first-page":"e72251","article-title":"Qiu M, Yang X, Hu J, Ding X, Jiang F, et al. Predictive Value of XPD Polymorphisms on Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis","volume":"8(8)","journal-title":"PLoS One"},{"key":"ref28","first-page":"315","article-title":"Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, et al. Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis","volume":"28(1)","journal-title":"Med Oncol"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Cheng H, Qin Q, Sun X, Li F, Sun N, <etal>et al<\/etal>.. (2013) Predictive Effect of XPA and XPD Polymorphisms on Survival of Advanced NSCLC Patients Treated with Platinum-based Chemotherapy: A Three-dimensional (3-D), Polyacrylamide Gel-Based DNA Microarray Method. Technol Cancer Res Treat.","DOI":"10.7785\/tcrt.2012.500337"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7314\/APJCP.2013.14.1.145","article-title":"Common variations of DNA repair genes are associated with response to platinum-based chemotherapy in NSCLCs","volume":"14","author":"XD Li","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12094-012-0785-3","article-title":"Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients","volume":"14","author":"X Chen","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s12032-011-0033-7","article-title":"DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy","volume":"29","author":"D Li","year":"2012","journal-title":"Med Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/JTO.0b013e31824fe98c","article-title":"Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine\/platinum","volume":"7","author":"WY Liao","year":"2012","journal-title":"J Thorac Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00280-012-1985-9","article-title":"Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer","volume":"70","author":"M Provencio","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e33200","DOI":"10.1371\/journal.pone.0033200","article-title":"Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients","volume":"7","author":"W Wu","year":"2012","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lungcan.2011.05.023","article-title":"Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy","volume":"75","author":"S Ren","year":"2012","journal-title":"Lung Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.7314\/APJCP.2012.13.6.2583","article-title":"Predictive role of ERCC1 and XPD genetic polymorphisms in survival of Chinese non-small cell lung cancer patients receiving chemotherapy","volume":"13","author":"ZY Zhang","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/JTO.0b013e3182307e1f","article-title":"Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin\/gemcitabine-treated advanced non-small cell lung cancer patients","volume":"6","author":"V Ludovini","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.lungcan.2010.05.005","article-title":"Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine","volume":"71","author":"N Vinolas","year":"2011","journal-title":"Lung Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lungcan.2010.11.004","article-title":"Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy","volume":"73","author":"L Liu","year":"2011","journal-title":"Lung Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/COC.0b013e3181b9cedc","article-title":"Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer","volume":"33","author":"F Li","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3816\/CLC.2009.n.015","article-title":"DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer","volume":"10","author":"A Kalikaki","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"ref43","first-page":"859","article-title":"Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers","volume":"10","author":"CY Yao","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2008.20.8793","article-title":"Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics","volume":"27","author":"DR Gandara","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/cncr.21885","article-title":"Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer","volume":"106","author":"R Booton","year":"2006","journal-title":"Cancer"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","article-title":"Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy","volume":"44","author":"JS Ryu","year":"2004","journal-title":"Lung Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3816\/CLC.2003.n.004","article-title":"Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine\/cisplatin-treated advanced non-small-cell lung cancer patients","volume":"4","author":"C Camps","year":"2003","journal-title":"Clin Lung Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0079864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:29:26Z","timestamp":1589009366000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0079864"}},"subtitle":[],"editor":[{"given":"Xiaoping","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0079864","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}